Los puntos clave no están disponibles para este artículo en este momento.
The precise associations between common clinical biomarkers and hepatocellular carcinoma (HCC) risk remain unclear but hold valuable insights for HCC risk stratification and prediction.
Liu et al. (Fri,) studied this question.